Skip to content
Site navigation Search

Dr. Clare Peyton

Associate Professor

Area
School of Chemistry & Biosciences
Faculty of Life Sciences
E-mail
C.Peyton@bradford.ac.uk
Phone
+441274238084
Dr. Clare Peyton

Biography

Dr. Peyton joined the University of Bradford in Sept 2016 and is now an Associate Professor in Biophysical Chemistry within the Department of Medical Sciences. Her background has spanned formulation and analytical chemistry in the pharmaceutical and FMCG industries, NMR method development, structural biology, protein and peptide synthesis, and computational biophysics. Her main focus of research is post-translational modifications that trigger deleterious conformations in peptides and proteins and the use of novel and non-natural amino acids in peptide drug design.

Dr. Peyton has been awarded grants from the Amyloidosis Foundation and the Academy of Medical Sciences to support her work examining the role of isomerisation in neurogenerative and cardiac disorders. Dr. Peyton also studies the conformational behaviours of metalloproteins and their role in disease. 

Dr. Peyton is a passionate educator and since April 2019 has been the Programme Lead of the BSc and MChem Undergraduate degree programmes at the University of Bradford and Interim Director of Studies for the School of Chemistry and Biosciences in 2021-2022. In 2024, Dr Peyton became Head of the School of Chemistry and Biosciences and, as of January 2026, Dr Peyton is now the Head of the Medical Sciences Department in the School of Pharmacy, Optometry and Medical Sciences. 
Dr Peyton was the recipient of the 2021 Bradford Teaching Fellow award https://www.bradford.ac.uk/news/archive/2021/chemistry-lecturer-praised-for-innovative-way-of-inspir...

Research

Dr. Peyton has a background that spans formulation and analytical chemistry in the pharmaceutical and FMCG industries, NMR method development, structural biology, protein and peptide synthesis, and computational biophysics. Her main focus of research is post-translational modifications that trigger deleterious conformations in peptides and proteins and the use of novel and non-natural amino acids in peptide drug design.

Dr. Peyton has been awarded grants from the Amyloidosis Foundation and the Academy of Medical Sciences to support her work examining the role of isomerisation in neurogenerative and cardiac disorders. 

Research projects

Role of Isomerisation in Cardiac Amyloidosis

Date
to
Role
Principal Investigator

Springboard Award from the Academy of Medical Sciences to examine the role of amino acid isomerisation in cardiac amyloidosis.

Teaching

Office Hours

Students can book meetings with Dr Peyton here.